PCSK9 and sleep apnea syndrome: Taken together, these findings and the results of the TSMR analysis suggest that the protective effect of HMGCR lipid-lowering drugs and PCSK9 inhibitors on sleep apnea syndrome may not be related to a reduction in the serum LDL-C concentration.